Related Experiment Video
Updated: Aug 5, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon regulatory factor 1 promoter polymorphism and response to type 1 interferon
1Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. hsaito@med.keio.ac.jp
Journal of Cellular Biochemistry. Supplement
|July 17, 2001
Summary
Interferon treatment effectiveness varies due to genetic differences. Single nucleotide polymorphisms in the interferon regulatory factor-1 gene promoter may influence how individuals respond to type 1 interferons, impacting liver cancer treatment outcomes.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
- Oncology
Background:
- Clinical success of interferon therapy shows significant inter-individual variability.
- Interferon regulatory factor-1 (IRF1) is a key transcription factor in the interferon system.
- IRF1 gene transcription levels correlate with the antiproliferative effects of type 1 interferons in liver cancer cells.
Purpose of the Study:
- To investigate if mutations in the interferon regulatory factor-1 (IRF1) gene contribute to differential responses to type 1 interferons.
- To analyze the impact of genetic variations in the IRF1 promoter region on gene transcription and interferon response.
Main Methods:
- DNA sequencing of the IRF1 gene and its upstream region from human liver cancer cell lines and peripheral blood mononuclear cells.
- Polymerase chain reaction (PCR) amplification of the IRF1 upstream region.
- Luciferase reporter assay to measure the promoter activity of the IRF1 upstream region.
Main Results:
- Four point mutations were identified in the upstream promoter region (-1 to -495) of the IRF1 gene.
- Luciferase assays confirmed that these mutations significantly altered the promoter activity of the IRF1 gene.
- Analysis revealed these mutations to be single nucleotide polymorphisms (SNPs) in the general population.
Conclusions:
- Single nucleotide polymorphisms (SNPs) in the interferon regulatory factor-1 (IRF1) promoter region are identified as potential determinants of type 1 interferon response.
- These genetic variations may partially explain the observed variability in clinical outcomes of interferon-based treatments, particularly in liver cancer.
Related Concept Videos
02:16Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
02:36RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
01:30General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...